Lifecore Biomedical, Inc. Operating Income for the Trailing 12 Months (TTM) ending February 23, 2025: USD -19.68 M

Lifecore Biomedical, Inc. Operating Income is USD -19.68 M for the Trailing 12 Months (TTM) ending February 23, 2025, a 30.36% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
  • Lifecore Biomedical, Inc. Operating Income for the Trailing 12 Months (TTM) ending February 25, 2024 was USD -15.10 M, a -37.89% change year over year.
  • Lifecore Biomedical, Inc. Operating Income for the Trailing 12 Months (TTM) ending February 26, 2023 was USD -24.31 M, a 148.30% change year over year.
  • Lifecore Biomedical, Inc. Operating Income for the Trailing 12 Months (TTM) ending February 28, 2022 was USD -9.79 M, a -64.83% change year over year.
  • Lifecore Biomedical, Inc. Operating Income for the Trailing 12 Months (TTM) ending February 28, 2021 was USD -27.84 M, a 21.31% change year over year.
Key Data
Date Operating Income EBIT EBITDA Net Income